Literature DB >> 8441170

Geographic variation in the prevalence of Raynaud's phenomenon: Charleston, SC, USA, vs Tarentaise, Savoie, France.

H R Maricq1, P H Carpentier, M C Weinrich, J E Keil, A Franco, P Drouet, O C Ponçot, M V Maines.   

Abstract

We estimated the prevalence of Raynaud's phenomenon (RP) in the general population of 2 geographic areas, Charleston County, South Carolina, USA, and Tarentaise, Savoie, France, using the same methodology in both countries. The first phase of the study, consisting of the telephone survey of a randomly drawn sample of households, yielded 2086 completed interviews in Charleston and 2000 in Tarentaise. Cold sensitivity or unusual digital color changes were reported by 17.9% of the subjects in Charleston and by 31.3% in Tarentaise. In the second phase of the study the diagnosis of RP was made by a medical team. Based on these results, the estimated prevalence of RP is 5.0% (0.8% SE) in Charleston (women 5.7%, men 4.3%) and 16.8% (2.0% SE) in Tarentaise (women 20.1%, men 13.5%).

Entities:  

Mesh:

Year:  1993        PMID: 8441170

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  16 in total

Review 1.  Raynaud's phenomenon: epidemiology and risk factors.

Authors:  Liana Fraenkel
Journal:  Curr Rheumatol Rep       Date:  2002-04       Impact factor: 4.592

2.  The effects of stress, anxiety, and outdoor temperature on the frequency and severity of Raynaud's attacks: the Raynaud's Treatment Study.

Authors:  K M Brown; S J Middaugh; J A Haythornthwaite; L Bielory
Journal:  J Behav Med       Date:  2001-04

3.  Raynaud's Phenomenon.

Authors: 
Journal:  Curr Treat Options Cardiovasc Med       Date:  2000-06

4.  Prevalence of Raynaud's phenomenon in a healthy Greek population.

Authors:  P V Voulgari; Y Alamanos; D Papazisi; K Christou; C Papanikolaou; A A Drosos
Journal:  Ann Rheum Dis       Date:  2000-03       Impact factor: 19.103

5.  Predictive value of nailfold capillaroscopy in patients with Raynaud's phenomenon.

Authors:  Madeleine Meli; Gabriela Gitzelmann; Renate Koppensteiner; Beatrice R Amann-Vesti
Journal:  Clin Rheumatol       Date:  2005-06-11       Impact factor: 2.980

Review 6.  [Raynaud phenomenon in dermatology. Part 1: Pathophysiology and diagnostic approach].

Authors:  C Sunderkötter; G Riemekasten
Journal:  Hautarzt       Date:  2006-09       Impact factor: 0.751

7.  Raynaud's phenomenon: prevalence in an Italian population sample.

Authors:  Rossella De Angelis; Fausto Salaffi; Walter Grassi
Journal:  Clin Rheumatol       Date:  2005-11-15       Impact factor: 2.980

8.  Perfusion Scintigraphy for the Evaluation of Patients with Raynaud's Phenomenon.

Authors:  Ari Chong
Journal:  Nucl Med Mol Imaging       Date:  2020-10-22

9.  Raynaud's phenomenon and digital ischemia: a practical approach to risk stratification, diagnosis and management.

Authors:  Zsuzsanna H McMahan; Fredrick M Wigley
Journal:  Int J Clin Rheumtol       Date:  2010

10.  How do patients define Raynaud's phenomenon? Differences between primary and secondary disease.

Authors:  Susan L Murphy; Alain Lescoat; Mary Alore; Michael Hughes; John D Pauling; Maya Sabbagh; Dinesh Khanna
Journal:  Clin Rheumatol       Date:  2021-01-24       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.